Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04533503 · ClinicalTrials.gov registry record
Vis-Rx Post-Market Evaluation
A clinical trial, sponsored by Gentuity.
- Completed
- Registry status
- 257
- Enrollment target
NCT04533503 is a clinical trial that has completed, run by Gentuity. The registered enrollment target is 257 participants.
The verdict
NCT04533503 has completed, sponsored by Gentuity.
- COMPLETED
- Registry status
- 257 participants
- Enrollment target
Study Summary
Post-market clinical evaluation of the Gentuity High-Frequency Optical Coherence Tomography (HF-OCT) System and the Vis-Rx Micro-Imaging Catheter for use in Percutaneous Coronary Intervention (PCI) procedures.
Interventions
- DEVICE HF-OCT Imaging with the Vis-Rx Micro-Imaging Catheter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 257 participants |
| Start Date | 2021-02-22 |
| Est. Completion | 2023-01-25 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04533503
The ClinicalTrials.gov registry entry for NCT04533503 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 257 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Gentuity, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which HF-OCT Imaging with the Vis-Rx Micro-Imaging Catheter is the first listed.
NCT04533503 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04533503 about?
NCT04533503 is a clinical study titled "Vis-Rx Post-Market Evaluation". Post-market clinical evaluation of the Gentuity High-Frequency Optical Coherence Tomography (HF-OCT) System and the Vis-Rx Micro-Imaging Catheter for use in Percutaneous Coronary Intervention (PCI) procedures.
What is the current status of trial NCT04533503?
This trial is currently completed. The enrollment target is 257 participants. The study started on 2021-02-22. Estimated completion is 2023-01-25.
What interventions are being tested in trial NCT04533503?
The interventions under investigation include: HF-OCT Imaging with the Vis-Rx Micro-Imaging Catheter (DEVICE).
Who is sponsoring clinical trial NCT04533503?
This trial is sponsored by Gentuity, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.